| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
CH:NOVN
Novartis AG
|
Jun 11, 2026 | BUY |
Buy
-11.2% avg upside
30 analysts
|
$135.00
11.48% Upside
|
· |
|
GB:0QIU
Novo Nordisk
|
May 07, 2026 | HOLD |
Hold
+43.5% avg upside
28 analysts
|
$250.00
10.91% Downside
|
· |
|
CH:GALD
Galderma Group AG
|
Apr 27, 2026 | HOLD |
Strong Buy
+6.3% avg upside
9 analysts
|
$160.00
7.45% Downside
|
· |
|
NVS
Novartis
|
Mar 26, 2026 | BUY |
Hold
-9.3% avg upside
24 analysts
|
$170.00
12.65% Upside
|
+0.8% |
|
DE:BAYN
Bayer
|
Mar 11, 2026 | BUY |
Strong Buy
+32.5% avg upside
27 analysts
|
$53.00
40.50% Upside
|
· |
|
ES:GRF
Grifols
|
Mar 10, 2026 | HOLD |
Buy
+63.8% avg upside
12 analysts
|
$11.00
22.13% Upside
|
· |
|
NVO
Novo Nordisk
|
Mar 03, 2026 | HOLD |
Buy
+166.9% avg upside
26 analysts
|
$40.00
8.09% Downside
|
+24.1% |
|
INDV
Indivior
|
Dec 03, 2025 | BUY |
Strong Buy
+11.7% avg upside
7 analysts
|
$36.00
5.11% Downside
|
+11.5% |
|
CH:SDZ
Sandoz Group Ltd
|
Dec 03, 2025 | HOLD |
Buy
-6.7% avg upside
9 analysts
|
$50.00
27.24% Downside
|
· |
|
ALVO
Alvotech
|
Dec 03, 2025 | BUY |
Buy
+104.7% avg upside
6 analysts
|
$10.00
155.40% Upside
|
-28.9% |
|
CH:LONN
Lonza Group Ltd
|
Dec 03, 2025 | BUY |
Strong Buy
+28.3% avg upside
19 analysts
|
$650.00
31.82% Upside
|
· |
|
DE:MRK
Merck KGaA
|
Dec 03, 2025 | HOLD |
Buy
-1.1% avg upside
31 analysts
|
$135.00
1.14% Upside
|
· |
|
FR:DIM
Sartorius Stedim Biotech
|
Apr 22, 2025 | BUY |
Strong Buy
+48.9% avg upside
9 analysts
|
$250.00
41.55% Upside
|
· |
|
DE:SRT3
Sartorius
|
Apr 22, 2025 | BUY |
Buy
+26.0% avg upside
16 analysts
|
$300.00
31.49% Upside
|
· |
|
GB:0QW0
arGEN X
|
Mar 05, 2025 | BUY |
Strong Buy
-22.6% avg upside
24 analysts
|
$715.00
5.86% Downside
|
· |
|
GB:HIK
Hikma Pharmaceuticals
|
Feb 12, 2025 | HOLD |
Buy
+61.1% avg upside
6 analysts
|
$2400.00
64.08% Upside
|
· |
|
DE:EVT
Evotec
|
Jul 29, 2024 | HOLD |
Buy
+259.1% avg upside
8 analysts
|
$12.00
153.68% Upside
|
· |
|
EVO
Evotec AG
|
Jul 29, 2024 | HOLD |
Strong Buy
+281.7% avg upside
9 analysts
|
$13.94
433.90% Upside
|
-10.9% |
|
GB:BEZ
Beazley
|
Jul 15, 2024 | BUY |
Strong Buy
+247.4% avg upside
9 analysts
|
$912.00
28.88% Downside
|
· |
|
FR:IPN
Ipsen
|
May 15, 2024 | HOLD |
Buy
-22.4% avg upside
17 analysts
|
$120.00
24.46% Downside
|
· |
|
SDZNY
Sandoz Group Ltd Sponsored ADR
|
May 08, 2024 | HOLD |
Buy
-48.3% avg upside
2 analysts
|
$40.38
52.79% Downside
|
+32.2% |
|
CH:IDIA
Idorsia Ltd
|
Apr 03, 2024 | SELL |
Hold
-22.9% avg upside
8 analysts
|
$1.00
78.46% Downside
|
· |
|
GB:0NZT
UCB SA
|
Mar 25, 2024 | HOLD |
Buy
-13.5% avg upside
19 analysts
|
$105.00
58.51% Downside
|
· |
|
GRFS
Grifols SA
|
Dec 29, 2023 | HOLD |
Buy
+230.3% avg upside
11 analysts
|
$16.26
117.95% Upside
|
-33.8% |
|
ES:ALM
Almirall
|
Nov 13, 2023 | HOLD |
Buy
+17.6% avg upside
5 analysts
|
$11.00
2.92% Downside
|
· |
|
TEVA
Teva Pharmaceutical
|
Oct 04, 2023 | HOLD |
Buy
-8.1% avg upside
39 analysts
|
$10.00
69.20% Downside
|
+90.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.